In 1265 women with early breast cancer needing nodal radiotherapy (1221 analysed), 40 Gy in 15 fractions was non-inferior to 50 Gy in 25 fractions for arm lymphoedema (HR 1.02; 3-year incidence 23.4% vs 22.2%); grade 3+ adverse events 8% vs 13%.
RCTn = 1,265
Rivera et al. 5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial